昆明哪个看妇科医院好昆明妇科哪里医院好,昆明妇科好,昆明怀孕一月能做药流吗,昆明五华区看妇科的医院,昆明台俪妇产医院在线预约,昆明区台俪妇科医院,昆明那个医院看妇科比较好

In a recent tweet, Elon Musk said his Hyperloop tunnel for rapid transportation is nearly complete.The high-speed tunnel he is building is expected to open Dec.10, according to Musk's Twitter page. It will run under Hawthone, California, near Los Angeles, and transport people between Dodger Stadium and nearly metro stations in less than 4 minutes, according to foxbusiness.com.Musk is making no guarantees about the work his tunneling company, called Boring Company, is doing. On the Joe Rogan Experience podcast, he said it started as a joke because he hates Los Angeles traffic so much, but then he decided to realize the idea.Musk doesn't see his version of Hyperloop involving stations such as current commuter rails have. His will have small stations the size of parking spaces and involve van-like vehicles as part of the transport. 863

In an interview with Axios, which aired Monday night, President Donald Trump said he again believes that his administration has the coronavirus pandemic "under control," despite the fact that deaths linked to the virus are currently on the rise throughout the country.When Axios reporter Jonathan Swan pointed out to Trump that deaths are on the rise, Trump said it's as "under control as much as you can control it.""(Americans) are dying, that's true, and it is what it is," Trump said. "But that doesn't mean we aren't doing everything we can. It's under control, as much as you can control it. This is a horrible plague that beset us."Trump also reiterated the false claim that virus cases are on the rise in the U.S. solely because the country is doing more testing than any other country."Because we're so much better at testing that any other country in the world, we show more cases," Trump said.While the U.S. is conducting more tests than any other country, other statistics, like hospitalizations linked to the virus and deaths linked to the virus, are currently on the rise. In addition, Johns Hopkins reports that 7.7 percent of all COVID-19 tests in the U.S. are coming back positive — in South Korea, the positive test rate currently sits at 0.9 percent.Trump also attempted to prove through statistics that the United States' mortality rate was among the best in the world. He handed Swan a piece of paper that showed the U.S. mortality rate was falling among a proportion of confirmed cases.Swan then pointed out that the United States ranked among the worst in the world when viewing COVID-19 deaths as a proportion of the population."You can't do that," Trump said.Trump also stated in the interview that some experts have said that "you can test too much." When asked who was saying that, Trump told Swan to "read the manuals, read the books."None of Trump's top health experts have publicly advocated for less testing. Earlier this year, Dr. Anthony Fauci and several other coronavirus task force members said during a House hearing that they had not been directed to "slow down" testing, and said it was the administration's goal to conduct more testing.During that same interview, Trump also told Swan that he "wasn't sure" how history would view the legacy of Rep. John Lewis. 2308

IMPERIAL BEACH, Calif. (KGTV) - Residents in one Imperial Beach neighborhood are hoping surveillance video will help put an end to an "endless" cycle of graffiti.In an alley off 14th Street, Gary Copeland looks at his neighbor's brand new fence and can only shake his head."It's disgusting we have to look at all this graffiti," said Copeland.On Monday around 4:30 a.m., a neighbor's motion-activated camera captured a man in a cap shaking a can of spray paint. In the next video recorded, one can hear the sound of spray paint before the man emerges from the dark. Hours later and blocks away, a camera in another alley captured a man without a cap spray-painting a similar tag on the wall of another home."It's a nuisance is what it is," said Copeland.Copeland's family has lived at his home for some four decades."You can see they've tagged my wall a few times. We've repainted, but they came back and re-tagged it," said Copeland.Copeland says his wall has been hit three times in the past six months."It's never-ending deal ... there's always tagging. Up and down the alley all these fences are tagged ... It takes your sense of living in a good home and neighborhood to feeling like you're living in a slum," said Copeland.If you have any information on the cases, call the Imperial Beach sheriff's station at 619-498-2400. 1339

If another stimulus package is approved, there is a possibility it would include a ,000 travel tax credit. It’s an effort to kickstart the hospitality industry.The tax credit would cover vacation-related expenses through 2021.Experts agree there needs to be a way to jumpstart the economy.It may not be the right time to travel, though.Right now, we are seeing a continuation of the first wave of the virus. A second wave of is expected between the end of the summer and early fall, models show.“It'll dip down and it'll come up again, a resurgence of the same strain,” said Dr. Jay Wolfson, a public health professor at the University of South Florida. “And then we also have reason to believe there will be a mutation of this virus that will occur at the same time in the late summer, early fall.”Dr. Anthony Fauci has said it is possible a vaccine would be available by the end of this year, but Wolfson says having a vaccine doesn't automatically make public places safe again.“It would take a good year or so if you're lucky, once you’ve got a vaccine produced, and a vaccine that's not going to have some adverse effects in a sector of the population,” said Wolfson.It's only been three months since much of Europe went through its peaks of coronavirus. Some countries just started reopening to tourists, but not to Americans yet. 1346

How accurate are the coronavirus tests used in the U.S.?Months into the outbreak, no one really knows how well many of the screening tests work, and experts at top medical centers say it is time to do the studies to find out.When the new virus began spreading, the Food and Drug Administration used its emergency powers to OK scores of quickly devised tests, based mainly on a small number of lab studies showing they could successfully detect the virus.That’s very different from the large patient studies that can take weeks or months, which experts say are needed to provide a true sense of testing accuracy.The FDA’s speedy response came after it was initially criticized for delaying the launch of new tests during a crisis and after the Centers for Disease Control and Prevention stumbled in getting its own test out to states.But with the U.S. outbreak nearly certain to stretch on for months or even years, some experts want the FDA to demand better evidence of the tests’ accuracy so doctors know how many infections might be missed.There have been more than 2 million confirmed coronavirus cases in the U.S. and more than 115,000 deaths, according to data compiled by Johns Hopkins University. Cases in nearly half of U.S. states are rising.In recent weeks, preliminary findings have flagged potential problems with some COVID-19 tests, including one used daily at the White House. Faulty tests could leave many thousands of Americans with the incorrect assumption that they are virus-free, contributing to new flare-ups of the disease as communities reopen.“In the beginning, the FDA was under a lot of pressure to get these tests onto the marketplace,” said Dr. Steven Woloshin of Dartmouth College, who wrote about the issue in the New England Journal of Medicine last week. “But now that there are plenty of tests out there, it’s time for them to raise the bar.”The FDA said in a statement that it has already asked multiple test makers to do follow-up accuracy studies, although it didn’t say for how many of the more than 110 authorized screening tests. The agency also said it is tracking reports of problems. Accuracy has also been an issue with blood tests that look for signs of past infections.No screening test is 100% accurate. So details on accuracy are routinely provided for tests of all types, including seasonal flu, hepatitis, HIV and cancers. For example, rapid flu tests are known to miss 20% or more of all cases, a factor doctors weigh when treating patients who have symptoms but test negative.For now, most COVID-19 tests in the U.S. don’t give data on real-world performance, including how often the tests falsely clear patients of infection or falsely detect the virus. That information is lacking for all but a few of the roughly 80 commercial screening tests available, according to an Associated Press review.The government’s emergency authorization process “requires a lower level of evidence,” the agency said. Makers need only show that a test “may be effective” instead of the usual requirement to demonstrate “safety and effectiveness.” They would have to meet that higher threshold once the U.S. government declares the emergency over.Many of the commercial test makers submitted results from 60 samples, the minimum number required and mostly used lab-produced specimens of the virus. The FDA now recommends the use of nasal swabs or other real samples from people screened for coronavirus.Experts say larger patient studies patients are needed to assess a test’s true performance.Lab testing bears little resemblance to actual — sometimes imperfect — conditions at hospitals, clinics and testing sites noted Dr. Robert Kaplan of Stanford University.“You’re testing people in parking lots, the patients themselves are extremely anxious and often unable to follow instructions,” said Kaplan, a former associate director of the National Institutes of Health.Kaplan and others say those differences could explain why some tests are not performing as expected.Last month, the FDA warned doctors of a potential accuracy problem with Abbott Laboratories’ rapid ID Now test, which delivers results in roughly 15 minutes. The test has been lauded by President Donald Trump and used to screen the president, his staff and visitors to the White House.The FDA alert followed a preliminary report by New York University that found Abbott’s test missed between a third to one-half of infections caught by a rival test in patients screened for the virus.Abbott rejected the findings, saying the researchers did not follow the instructions for using its test. The company pointed to alternate patient studies, including its own, that have found the test successfully detects between 91% and 95% or more of virus cases when compared to other tests.But similar problems with ID NOW’s accuracy have been flagged in preliminary reports by researchers at Stanford University, Loyola University and the Cleveland Clinic.For now, the FDA is requiring Abbott to conduct follow-up studies in several different patient groups.The FDA’s emergency standards “are still high but there is a significant difference in the body of work that what would go into a submission under the normal process,” said Abbott vice president John Hackett. “Our normal process takes years to bring these out.”Requiring bigger studies of all coronavirus tests could provide valuable information, but it could also strain the FDA’s already stretched staff and resources, said Dr. Daniel Schultz, former director of the FDA’s medical device center.Dr. Colin West of the Mayo Clinic worries doctors and patients have put too much confidence in the current crop of tests, when an unknown number of patients with COVID-19 are likely receiving false negative results.Even a modest error rate can have grave consequences during an outbreak like COVID-19. West gives the example of a test that is 95% accurate at detecting the virus and is used on 1 million people. That would still result in 50,000 people being incorrectly told that they don’t have the virus.“The negative test does not mean that I’m off the hook,” West said. “We just need to maintain that level of vigilance until we have a better sense of how good these tests really can be.”___Follow Matthew Perrone on Twitter: @AP_FDAwriter.___Follow AP pandemic coverage at http://apnews.com/VirusOutbreak and https://apnews.com/UnderstandingtheOutbreak.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6604